Vascular endothelin-1 gene expression and effect on blood pressure of chronic ET(A) endothelin receptor antagonism after nitric oxide synthase inhibition with L-NAME in normal rats

Circulation

Volumn 95, Issue 1, 1997, Pages 240-244

  Sventek, Pavol ^a   Turgeon, André ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

angiotensin; arteries; hypertension; hypertrophy

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HYPERTENSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0031014501     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.1.240     Document Type: Article

References (13)

1. Rees DD, Palmer RJJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A. 1989;86:3375-3378.
2. G-nitro-L-arginine methyl ester in conscious Brattelboro rats. Br J Pharmacol. 1990;101:10-12.
3. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension. 1992;20:298-303.
4. Deng LY, Thibault G, Schiffrin EL. Effect of hypertension induced by nitric oxide synthase inhibition on structure and function of resistance arteries in the rat. Clin Exp Hypertens. 1993;15:527-537.
5. Li J-S, Schiffrin EL. Resistance artery structure and neuroeffector mechanisms in hypertension induced by inhibition of nitric oxide synthase. Am J Hypertens. 1994;7:996-1004.
6. Salazar FJ, Alberola A, Pinilla JM, Romero JC, Quesada T. Saltinduced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension. 1993;22:49-55.
7. Jover B, Herizi A, Ventre F, Dupon M, Mimran A. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension. 1993;21:944-948.
8. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
9. Amal JF, El Amrani A-I, Chatellier G, Ménard J, Michel J-B. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension. 1993;22:380-387.
10. Dunn WR, Gardiner SM. No evidence of vascular remodeling during hypertension induced by chronic inhibition of nitric oxide synthase in Brattleboro rats. J Hypertens. 1995;13:849-857.
11. Schiffrin EL. Vascular structure in L-NAME-induced hypertension: methodological considerations for studies of small arteries in hypertension. J Hypertens. 1995;13:817-821. Editorial.
12. Vanhoutte PM. Is endothelin involved in the pathogenesis of hypertension? Hypertension. I993;21:747-751.
13. Lüscher TF, Seo B, Bühler FR. Potential role of endothelin in hypertension. Hypertension. 1993;21:752-757.